Methyldopa in the treatment of hypertension

scientific article published on 01 April 1962

Methyldopa in the treatment of hypertension is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(62)91782-8
P698PubMed publication ID13866047

P2093author name stringR I BAYLISS
E A HARVEY-SMITH
P2860cites workInhibition of dihydroxy-phenylalanine decarboxylase by derivatives of phenylalanineQ73580446
Clinical pharmacology of newer anthypertensive agents, monoamine oxidase and decarboxylase inhibitors, bretvlium tosvlate, and guanethidineQ78848949
Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineQ78849316
Clinical and pharmacological studies with guanethidine in the treatment of hypertensionQ79216756
Serotonin synthesis in carcinoid patients. Its inhibition by alpha-methyl-dopa, with measurement of associated increases in urinary 5-hydroxytryptophanQ79264295
P433issue7233
P407language of work or nameEnglishQ1860
P921main subjectmethyldopaQ412621
P304page(s)763-768
P577publication date1962-04-01
P1433published inThe LancetQ939416
P1476titleMethyldopa in the treatment of hypertension
P478volume1

Reverse relations

cites work (P2860)
Q723380503. Animal experimentation leading to the development of drugs benefiting human beings and animals
Q35440834ALPHA-METHYLDOPA IN THE TREATMENT OF HYPERTENSION.
Q35539765Beta-adrenoreceptor blockade in hypertension
Q55037511CLINICAL TRIAL OF 2-GUANIDINOMETHYL (1,4) BENZODIOXAN (COMPOUND 1003).
Q39261746Diuretics as initial treatment for essential hypertension
Q55690431Double-blind trial of four hypotensive drugs (methyldopa and three sympatholytic agents).
Q49188263Effect of Antihypertensive Drugs on the "Intrinsic" Heart Rate
Q54702184Effects of Alpha‐Methyldopa on the Myocardial Blood Flow, Utilizing the Coincidence Counting Method
Q39368587Efficacy of antihypertensive drugs
Q68896519Guanabenz: a centrally acting, natriuretic antihypertensive drug
Q42055744HAeMODYNAMIC STUDIES WITH METHYLDOPA: EFFECT ON CARDIAC OUTPUT AND RESPONSE TO PRESSOR AMINES
Q84948186Hyperpyrexia During Treatment with Methyldopa
Q95810701METHYLDOPA IN TREATMENT OF HYPERTENSION DUE TO CHRONIC RENAL DISEASE
Q55352982METHYLDOPA IN TREATMENT OF SEVERE TOXAEMIA OF PREGNANCY.
Q24240065Methyldopa for primary hypertension
Q42234359Methyldopa hepatitis. Report of three cases
Q84947699Methyldopa in Hypertension
Q72755050Methyldopa in hypertension
Q44094662Multicentre General Practitioner Assessment of ‘Tenormin’ and Methyldopa
Q42184545Natriuretic and water diuretic effects of guanabenz, a central alpha-2 agonist
Q67441269Oxprenolol in Hypertension. A Report on 2,770 Patients in General Practice Originally Treated with Methyldopa
Q71776920Relationship of extracellular fluid volume to the development of drug resistance in the hypertensive patient
Q41391081SOME OBSERVATIONS ON THE PHARMACOLOGY OF ALPHA-METHYLDOPA.
Q28363952Side Effects of Hypotensive Agents Evaluated by a Self-administered Questionnaire
Q36770574Some aspects of the long-term treatment of severe hypertension with methyldopa
Q40817384Stereochemical course in vivo of alpha-methyldopa decarboxylation in rat brains
Q44083117Studies on the pharmacology of α-methyl-3,4-dihydroxyphenylalanine (α-methyl-DOPA) and α-methylnorepinephrine Part II
Q76851018THE PROLONGED USE OF ALPHA METHYLDOPA IN THE TREATMENT OF HYPERTENSION
Q42918796The metabolism of14C-labelled α-methyldopa in normal and hypertensive human subjects
Q93744937To-day's Drugs
Q93932663To-day's Drugs
Q93664186Treatment of Pre-eclampsia or Toxaemia of Pregnancy
Q71166827Treatment of hypertension with methyldopa
Q79512594Treatment of severe hypertension with methyldopa
Q79614651[The effect of intravenously administered DOPA on the blood pressure in pretreated alpha-methyl-DOPA hypertensives. Studies on the blood pressure-lowering mechanism of alpha-methyl-DOPA]